Trivarx Limited has released a press release.
June 2026 Quarterly Activities Report and Appendix 4C
Earlier from Trivarx
- Stabl-Im clinical trial supply milestone achieved
- CRO Engaged to Advance Stabl-Im Phase 1 Trial
- March 2026 Quarterly Activities Report and Appendix 4C
- Dr Danielle Meyrick appointed as CEO